Mouth ulcers treatment market expected to Grow at 3.5% by 2031, mouth ulcers are painful sores that can be developed in mucous membrane of oral cavity or at the underneath of gums and restricts individual’s ability to chew, bite or eat. Depending on the size, shape and number the mouth ulcer can be classified as minor ulcer (2-8 mm diameter), major ulcer (bigger and uneven edges) and herpetiform ulcer (bunch of smaller injuries with irregular shapes). The principle causes of mouth ulcer are viral or bacterial infection, drug reaction, tooth decay, dentures, mechanical trauma, emotional stress, nutrients deficiency, changes in hormonal level and food allergy. The prevalence of mouth ulcer is around 4% globally and aphthous ulcer is the most common affecting around 25% population worldwide. The mouth ulcer treatment market can be segmented on the basis of drug class such as corticosteroids, anesthetics, analgesics, antimicrobial and antihistamines. The mouth ulcer treatment market can also be segmented on the basis of formulation such as Gel, Spray, Mouthwash and Lozenges, while the mouth ulcer treatment market can be segmented as Aphthous stomatitis, Oral Lichen Planus and others on the basis of indication.
Increasing geriatric population, rising prevalence of mouth ulcer and growing health awareness among public to quit smoking would drive the mouth ulcer treatment market. The advanced healthcare infrastructure of developed countries along with high market entrance of variety of oral hygiene care products shall further fuel the growth of the mouth ulcer treatment market; whereas the lack of awareness about public health in developing nations and availability of substitute products like herbal remedies of oral care products restrain the growth of mouth ulcer treatment market. Additionally, the side-effects or adverse reactions of the chemicals used in formulations negatively influence the growth of the mouth ulcer treatment market.
North America market is anticipated to dominate the Mouth ulcers treatment market due to the technological advancement in the diagnostic procedures of oral and dental care. Lucrative growth in mouth ulcer treatment market is expected in Asia-Pacific region due to rising health awareness and cost-effective treatment procedures.
Key Players Identified for Mouth Ulcers Treatment Market include:
Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight Co, Inc., Colgate Palmolive Company, Dr. Reddy’s, GlaxoSmithKline, plc, Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, 3M And Other Notable Players.
This report offers:
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Mouth Ulcers Treatment market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Year | 2022 |
Unit | USD Million |
Segmentation | |
Drug Class
| |
Formulation
| |
Indication
| |
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report